AUG 14, 2026 · PHASE 1 TRIAL
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
ClinicalTrials.gov
Phase 1 trial in early-stage development assessing safety and preliminary antitumor activity; no results reported in this registry record.
Reported
Estimated enrollment86
PhasePhase 1
Primary outcome: Adverse events f…From first dose to 30 days after last dose…